
1. Circ Cardiovasc Interv. 2019 Nov;12(11):e007938. doi:
10.1161/CIRCINTERVENTIONS.119.007938. Epub 2019 Nov 7.

Infective Endocarditis Following Transcatheter Aortic Valve Replacement:
Comparison of Balloon- Versus Self-Expandable Valves.

Regueiro A(1), Linke(2), Latib(3), Ihlemann(4), Urena(5), Walther(6), Husser(7), 
Herrmann C(8), Nombela-Franco(9), Cheema(10), Le Breton H(11), Stortecky(12),
Kapadia(13), Bartorelli L(14), Sinning(15), Amat-Santos(16), Munoz-Garcia J(17), 
Lerakis(18), Gutíerrez-Ibanes(19), Abdel-Wahab(20), Tchetche(21), Testa(22),
Eltchaninoff(23), Livi(24), Castillo(25), Jilaihawi(26), Webb G(27), Barbanti
M(28), Kodali(29), de Brito Jr S(30), Ribeiro B(31), Miceli(32), Fiorina(33),
Actis Dato(34), Rosato F(35), Serra(36), Masson(37), Wijeysundera C(38), Mangione
A(39), Ferreira(40), Lima C(41), Carvalho A(42), Abizaid(43), Marino A(44),
Esteves(45), Andrea C.M.(46), Messika-Zeitoun(5), Himbert(5), Kim(6),
Pellegrini(7), Auffret(11), Nietlispach(47), Pilgrim(12), Durand(23), Lisko(18), 
Makkar R(26), Lemos(31), Leon B(29), Puri(1), San Roman(16), Vahanian(5),
Søndergaard(4), Mangner(2), Rodés-Cabau(1).

Author information: 
(1)Quebec Heart & Lung Institute, Laval University, Quebec City, Canada
(2)Heart Center, Leipzig University, Germany
(3)Interventional Cardiology Unit, Ospedale San Raffaele, Milan, Italy
(4)Righospitalet, Copenhagen, Denmark
(5)Bichat Hôpital, Paris, France
(6)Kerckhoff Klinik, Nauheim, Germany
(7)Deutsches Herzzentrum, München, Germany
(8)Hospital of the University of Pennsylvania, Philadelphia
(9)Cardiovascular Institute, Hospital Universitario Clinico San Carlos, Madrid,
Spain
(10)Division of Cardiology, St. Michaels Hospital, Toronto, Canada
(11)Centre Hospitalier Universitaire de Rennes, France
(12)Bern University Hospital (on behalf of Swiss Registry Centres), Switzerland
(13)Cleveland Clinic
(14)Centro Cardiologico Monzino, Milan, Italy
(15)Heart Center Bonn, Germany
(16)Hospital Clinico Universitario de Valladolid, Spain
(17)Department of Cardiology, Hospital Universitario Virgen de la Victoria,
Malaga, Spain
(18)Emory University School of Medicine, Atlanta
(19)Department of Cardiology, Instituto de Investigación Sanitaria Gregorio
Marañon, Hospital Gregorio Maranon, Madrid, Spain
(20)Heart Center, Bad Segeberg, Germany
(21)Clinique Pasteur, Toulouse, France
(22)IRCCS Pol. San Donato, Milan, Italy
(23)Hôpital Charles Nicolle, University of Rouen, France
(24)AOU Santa Maria della Misericordia, Udine, Italy
(25)Department of Cardiology, Hospital Universitario Reina Sofia, Cordoba, Spain
(26)Cedars-Sinai Heart Institute, Los Angeles
(27)Center for Heart Valve Innovation, St. Pauls Hospital, Vancouver, Canada
(28)Ferrarotto Hospital, Catania, Italy
(29)Columbia University Medical Center, New York
(30)Hospital Israelita Albert Einstein, Sao Paulo, Brazil
(31)Instituto Nacional Cardiovascular (INCOR), Sao Paulo, Brazil
(32)Fondazione Toscana G. Monasterio, Massa, Italy
(33)Ospedali Civili di Brescia, Italy
(34)Ospedali Mauriziano, Torino, Italy
(35)S. Cocre e Carle Cuneo, Italy
(36)Hospital Vall d’Hebron, Barcelona, Spain
(37)Centre Hospitalier de l’Universite de Montreal, Canada
(38)Sunnybrook Health Science Center, Toronto, Canada
(39)Hospital Beneficencia Portuguesa, Sao Paulo, Brazil
(40)Hospital Naval Marcilio Dias, Rio de Janeiro, Brazil
(41)Hospital Sao FranciscoSanta Clara, Porto Alegre, Brazil
(42)Hospital Pró-cardíaco, Rio de Janeiro, Brazil
(43)Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil
(44)Hospital Madre Teresa, Belo Horizonte, Brazil
(45)Hospital Sao Luiz, Sao Paulo, Brazil
(46)Clínica Sao Vicente, Rio de Janeiro, Brazil
(47)University Hospital Zurich, Switzerland

BACKGROUND: No data exist about the characteristics of infective endocarditis
(IE) post-transcatheter aortic valve replacement (TAVR) according to
transcatheter valve type. We aimed to determine the incidence, clinical
characteristics, and outcomes of patients with IE post-TAVR treated with
balloon-expandable valve (BEV) versus self-expanding valve (SEV) systems.
METHODS: Data from the multicenter Infectious Endocarditis After TAVR
International Registry was used to compare IE patients with BEV versus SEV.
RESULTS: A total of 245 patients with IE post-TAVR were included (SEV, 47%; BEV, 
53%). The timing between TAVR and IE was similar between groups (SEV, 5.5
[1.2-15] months versus BEV, 5.3 [1.7-11.4] months; P=0.89). Enterococcal IE was
more frequent in the SEV group (36.5% versus 15.4%; P<0.01), and vegetation
location differed according to valve type (stent frame, SEV, 18.6%; BEV, 6.9%;
P=0.01; valve leaflet, SEV, 23.9%; BEV, 38.5%; P=0.01). BEV recipients had a
higher rate of stroke/systemic embolism (20.0% versus 8.7%, adjusted OR: 2.46,
95% CI: 1.04-5.82, P=0.04). Surgical explant of the transcatheter valve (SEV,
8.7%; BEV, 13.8%; P=0.21), and in-hospital death at the time of IE episode (SEV, 
35.6%; BEV, 37.7%; P=0.74) were similar between groups. After a mean follow-up of
13±12 months, 59.1% and 54.6% of the SEV and BEV recipients, respectively, had
died (P=0.66).
CONCLUSIONS: The characteristics of IE post-TAVR, including microorganism type,
vegetation location, and embolic complications but not early or late mortality,
differed according to valve type. These results may help to guide the diagnosis
and management of IE and inform future research studies in the field.

DOI: 10.1161/CIRCINTERVENTIONS.119.007938 
PMID: 31694412  [Indexed for MEDLINE]

